News & Events about Celularity Inc.
Celularity Inc. (Nasdaq: CELU) (Celularity), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC (CH Trading Group), an international import, export and trading company, today announced that they have entered...
Celularity Inc. (Nasdaq: CELU) (Celularity), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC (CH Trading Group), an international import, export and trading company, today announced that they have entered...
Legacy studies employing a single treatment course oftwo infusions seven days apart demonstrated greatest benefit in three early studies Data support further investigation of novel genetically modifiedcell therapy in Crohns disease FLORHAM PARK, N.J., Jan. 06, 2023 (GLOBE NEWSWIRE) -- Celularity Inc...
Celularity Inc. (Nasdaq: CELU) (Celularity or the Company), a clinical-stage biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, today announced that it received Halal Certification of its business models, commercial stage biomaterial products, and...
Celularity, Inc. (Nasdaq: CELU) (Celularity or the Company), a clinical-stage biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, shared today that Chairperson, Founder and Chief Executive Officer Robert J. Hariri, M.D., Ph.D. addressed the Future...